Presentation is loading. Please wait.

Presentation is loading. Please wait.

The Top 10 List – Best Lessons Learned from FDA Warning Letters Walter Nowocin Medtronic, Inc./Minneapolis, Minnesota Measurement Science Conference 23.

Similar presentations


Presentation on theme: "The Top 10 List – Best Lessons Learned from FDA Warning Letters Walter Nowocin Medtronic, Inc./Minneapolis, Minnesota Measurement Science Conference 23."— Presentation transcript:

1 The Top 10 List – Best Lessons Learned from FDA Warning Letters Walter Nowocin Medtronic, Inc./Minneapolis, Minnesota Measurement Science Conference 23 March, 2012

2 Objectives Review metrology related warning letters over the past five years – the best of the best Have discussions involving best practices on avoiding similar occurrences Pass along lessons learned Learn about new FDA search site

3 Source of Data All data in this presentation was taken from the ‘FDA Electronic Freedom of Information Reading Room – Warning Letter and Responses’ http://www.fda.gov/foi/warning.htm In the past I used the FDA site to search the past twelve months of warning letters containing the words calibrate, calibrated, or calibration. For example in 2010, I searched a total of 437 warning letters with 15 having calibration issues.

4 FDA Warning Letter Search Site http://www.fda.gov/foi/warning.htm

5 FDA Form 483 ‘Reading Room’ http://www.fda.gov/AboutFDA/CentersOffices/ORA/ORAElectronicReadingRoom/default.htm www.fda.gov/AboutFDA/CentersOffices/ORA/ORAElectronicReadingRoom/default.htm

6 General Observations Over five years, warning letters have increased while calibration specific issues have decreased. Calibration issues tend to be basic; i.e. past due dates, no procedures, etc. If there are calibration issues, they are usually associated with many other quality system issues. Rarely a warning letter just for calibration. Most violations are to company specific requirements and not FDA requirements.

7 FDA Warning Letter Categories Quality System Regulation - 820 Medical Devices Current Good Manufacturing Practice – Finished Pharmaceuticals Good Laboratory Practice Regulations - Nonclinical Laboratory Studies Current Good Manufacturing Practice – API (Active Pharmaceutical Ingredient) FDA 501k Product Approval Process

8 820.72(a) – No Annual Cal; Failed on Demo of Cal – 7 Jan 08 Number 10

9 501(a)(2)(B) – Incorrect Use of ‘N/A’ – 28 April 2008 Number 9

10 820.70(i) Failure to Validate Computer Software – 25 Mar 2008 Number 8

11 cGMP for API – Failed to Calibrate within Intended Range (7 April 2011) Number 7

12 820.72 (b) – Cal Procedures; Accuracy and Precision (18 Sep 08) Validation of Heat Sealer No Calibration of Temperature Gauges for monitoring heat sealer Number 6

13 211 – Overdue Cal Trending (23 Dec 09) What Calibration Metrics are you monitoring for quality trends? Do you have established ‘trigger’ points for investigation action? Number 5

14 211.192 – Out of Specification Investigation (22 Apr 09) Analytical Lab finding, but is a lesson learned for Cal Labs. Number 4

15 820.72(b)(1) – Traceability to Reference Standard – 8 Dec 06 Number 3

16 211.68 – Original Calibration Data (7 May 09) Number 2

17 820.72(b)(2) – Self Calibration Program (26 Feb 09) Number 1

18 Any questions on these warning letters or Form 483s?


Download ppt "The Top 10 List – Best Lessons Learned from FDA Warning Letters Walter Nowocin Medtronic, Inc./Minneapolis, Minnesota Measurement Science Conference 23."

Similar presentations


Ads by Google